Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin E and intima media thickness progression in end-stage renal disease (VIPER) cohort

被引:13
作者
Boaz, M [1 ]
Iuliano, L
Himmelfarb, J
Matas, Z
Micheletta, F
McMonagle, E
Friedman, V
Natoli, S
Gvirtz, G
Biro, A
Smetana, S
Sabo, G
Gafter, U
Weinstein, T
机构
[1] E Wolfson Med Ctr, Epidemiol Unit, IL-58100 Holon, Israel
[2] E Wolfson Med Ctr, Biochem Lab, Holon, Israel
[3] E Wolfson Med Ctr, Inst Nephrol, Holon, Israel
[4] E Wolfson Med Ctr, Ultrasound Unit, Holon, Israel
[5] Univ Roma La Sapienza, Dept Internal Med, Rome, Italy
[6] Maine Med Ctr, Div Nephrol, Portland, ME 04102 USA
[7] Rabin Med Ctr, Petah Tiqwa, Israel
来源
NEPHRON CLINICAL PRACTICE | 2005年 / 100卷 / 04期
关键词
hemodialysis; oxysterols; oxidative stress;
D O I
10.1159/000085290
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Oxysterols are markers of oxidative stress, levels of which have not yet been reported in hemodialysis (HD) patients. This study was designed to compare levels of the oxysterols 7-ketocholesterol (7KC) and 7 beta-hydroxycholesterol (7 beta OH) between a cohort of HD patients and healthy controls. Methods: This nested cross-sectional study reflects baseline (preintervention) values for markers of oxidative stress, inflammation and nutrition status in the 160-member vitamin E and carotid intima media thickness progression in end-stage renal disease (VIPER) cohort (age 64.1 +/- 8.8, 33.5% female). Age- and sex-matched healthy volunteers served as controls. Plasma oxysterols 7KC and 7 beta OH were determined by isotope dilution gas chromatography/mass spectrometry. Results: Despite higher plasma alpha-tocopherol levels in HD patients than controls (36.0 +/- 9.3 vs. 31.8 +/- 8.4 mu mol/l, p = 0.007), 7KC levels (9.8 +/- 6.9 vs. 5.9 +/- 2.8 nmol/mmol cholesterol, p < 0.0001) and 7 beta OH levels (8.7 +/- 4.3 vs. 2.7 +/- 1.6 nmol/mmol cholesterol, p ! 0.0001) were higher in HD patients. The oxysterol 7 beta OH was significantly, inversely associated with prealbumin (r = -0.18, p = 0.03), though neither oxysterol was significantly associated with any other marker of oxidative stress, inflammation or nutrition status and did not discriminate for CVD in HD patients. Conclusions: Elevated levels of the oxysterols 7KC and 7 beta OH indicate that HD patients are in a state of oxidative stress compared to healthy controls. However, oxysterols 7KC and 7 beta OH did not appear to contribute additional information about oxidative stress among HD patients. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:C111 / C119
页数:9
相关论文
共 34 条
[1]   Comparative analysis of plasma and erythrocyte 7-ketocholesterol as a marker for oxidative stress in patients with diabetes mellitus [J].
Abo, K ;
Mio, T ;
Sumino, K .
CLINICAL BIOCHEMISTRY, 2000, 33 (07) :541-547
[2]  
Becker BN, 1997, J AM SOC NEPHROL, V8, P475
[3]   Epidemiology and demography of treated end-stage renal failure in the elderly: from the European Renal Association (ERA-EDTA) Registry [J].
Berthoux, F ;
Gellert, R ;
Jones, E ;
Mendel, S ;
Valderrabano, F ;
Briggs, D ;
Carrera, F ;
Cambi, V ;
Saker, L .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 :65-68
[4]   Oxysterols -: Friends, foes, or just fellow passengers? [J].
Björkhem, I ;
Diczfalusy, U .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) :734-742
[5]   Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis [J].
Boaz, M ;
Matas, Z ;
Biro, A ;
Katzir, Z ;
Green, M ;
Fainaru, M ;
Smetana, S .
KIDNEY INTERNATIONAL, 1999, 56 (03) :1078-1083
[6]   Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].
Boaz, M ;
Smetana, S ;
Weinstein, T ;
Matas, Z ;
Gafter, U ;
Iaina, A ;
Knecht, A ;
Weissgarten, Y ;
Brunner, D ;
Fainaru, M ;
Green, MS .
LANCET, 2000, 356 (9237) :1213-1218
[7]   Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients [J].
Boaz, M ;
Matas, Z ;
Biro, A ;
Katzir, Z ;
Green, M ;
Fainaru, M ;
Smetana, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (03) :438-444
[8]   Involvement of oxysterols and lysophosphatidylcholine in the oxidized LDL-induced impairment of serum albumin synthesis by HEPG2 cells [J].
Bourdon, E ;
Loreau, N ;
Davignon, J ;
Bernier, L ;
Blache, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2643-2650
[9]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[10]  
DUARGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205